Provided is a kynurenine production inhibitor comprising a nitrogen-containing heterocyclic compound represented by formula (I):
(wherein R
50
and R
51
may be the same or different and each represent a hydrogen atom or the like, G
1
and G
2
may be the same or different and each represent a nitrogen atom or the like, X represents formula (III):
(wherein m
1
and m
2
may be the same or different and each represent an integer of 0 or 1, Y represents an oxygen atom or the like, and R
6
and R
7
may be the same or different and each represent a hydrogen atom or the like),
R
1
represents optionally substituted lower alkyl or the like, R
2
represents a hydrogen atom or the like, and R
3
represents optionally substituted lower alkyl or the like), and the like.
Substituted 2,3-Dihydrobenzofuranyl Compounds And Uses Thereof
申请人:KARYOPHARM THERAPEUTICS INC.
公开号:US20160221994A1
公开(公告)日:2016-08-04
The invention generally relates to substituted 2,3-dihydrobenzofuranyl compounds, and more particularly to a compound represented by Structural Formula (I), or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of Structural Formula (I), or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders.
Highly <i>E</i>-Selective Solvent-Free Horner-Wadsworth-Emmons Reaction for the Synthesis of α-Methyl-α,β-Unsaturated Esters Using Either LiOH·H<sub>2</sub>O or Ba(OH)<sub>2</sub>·8H<sub>2</sub>O
作者:Kaori Ando、Wakana Isomura、Nariaki Uchida、Kanae Mori
DOI:10.1246/bcsj.20220052
日期:2022.6.15
Horner-Wadsworth-Emmons reaction, which stirs a mixture of aldehyde, phosphonate reagent 1, and a base without solvent. The reaction of aromatic aldehydes and triethyl 2-phosphonopropionate 1a using LiOH·H2O gave 95-99% E-selectivity in 83-97% yield. The reaction of 1a with aliphaticaldehydes gave 92-94% E-selectivity except for α-branched aldehydes, and the selectivity was improved to 97-98% using ethyl 2-(diis
( E )-α-甲基-α,β-不饱和酯通过Horner-Wadsworth-Emmons 反应制备,该反应在无溶剂的情况下搅拌醛、膦酸酯试剂1和碱的混合物。芳香醛和 2-膦酰基丙酸三乙酯1a使用 LiOH·H 2 O 反应得到 95-99% E-选择性,产率为 83-97%。1a与脂肪醛的反应产生92-94% E-选择性,除了 α-支链醛,使用 2-(二异丙基膦酰基)丙酸乙酯1b将选择性提高到 97-98% 。使用 2-膦酰基丙酸三异丙酯1c改善了与 α-支链脂肪醛的反应和Ba(OH) 2 ·8H 2 O,得到98->99%的E-选择性和高产率。在THF中使用Ba(OH) 2 ·8H 2 O的HWE反应也以高产率高度选择性地得到( E )-α-甲基-α,β-不饱和酯。
Acrylamide derivatives as antiallergic agents. 2. Synthesis and structure activity relationships of N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-3-(3-pyridyl)acrylamides
作者:Yoshinori Nishikawa、Tokuhiko Shindo、Katsumi Ishii、Hideo Nakamura、Tatsuya Kon、Hitoshi Uno
DOI:10.1021/jm00123a012
日期:1989.3
A new series of 3-(3-pyridyl)acrylamides 16, 17, 19, and 26, and 5-(3-pyridyl)-2,4-pentadienamides 20-25 were prepared and evaluated for their antiallergic activity. Several of these compounds exhibited more potent inhibitory activities than the parent compound 1a [(E)-N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-3- (3-pyridyl)acrylamide] against the rat passive cutaneous anaphylaxis (PCA) reaction and the enzyme 5-lipoxygenase. Particularly, (E)-N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-3- (6-methyl-3-pyridyl)acrylamide (17p) showed an ED50 value of 3.3 mg/kg po in the rat PCA test, which was one-fifth of ketotifen and oxatomide. As compared with ketotifen and oxatomide, compound 17p (AL-3264) possessed a better balance of antiallergic properties due to inhibition of chemical mediator release, inhibition of 5-lipoxygenase, and antagonism of histamine.
Dhavale, Dilip D.; Sindkhedkar, Milind D.; Mali, Raghao S., Journal of Chemical Research - Part S, 1995, # 10, p. 414 - 415
作者:Dhavale, Dilip D.、Sindkhedkar, Milind D.、Mali, Raghao S.